Search clinical trials for: Rivastigmine Transdermal System

Total 77610 results

University of Bristol
Royal United Hospitals Bath NHS Foundation Trust

Recruiting

CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease) (CHIEF PD)

Parkinson Disease

United Kingdom
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Effect of Heat on Rivastigmine TDS Products

Bioavailability

United States
Novartis

Completed

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Alzheimer's Disease

United States
University of Maryland, Baltimore
National Institute on Aging (NIA)

Completed

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Parkinson Disease | Parkinson Disease Dementia

United States
The Cleveland Clinic

Terminated

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Mild Cognitive Impairment | Mild Cognitive Disorder

United States
University of Pennsylvania

Completed

Mild Cognitive Impairment in Parkinson's Disease

Parkinson's Disease | Mild Cognitive Impairment

United States
Novartis Pharmaceuticals

Completed

A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease (BETTER)

Alzheimer's Disease

Israel
Novartis

Completed

An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Alzheimer's Disease
Novartis

Completed

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Parkinson's Disease Dementia

United States, Belgium, Italy, United Kingdom, Germany, Australia, Austria, Spain, Canada, France, Netherlands, Turkey, Argentina
Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Dementia, Alzheimer Type | Alzheimer's Disease

Poland, Taiwan, United States, Israel, Denmark, Korea, Republic of, Peru, Russian Federation, Chile, Italy, Mexico, Norway, Sweden, Slovakia, Czechia, Portugal, Finland, Guatemala, Germany, Puerto Rico, Venezuela
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
UMC Utrecht
St. Antonius Hospital; ZonMw: The Netherlands Organisation for Health Research... and other collaborators

Recruiting

Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine (PRECISER)

Depressive Disorder

Netherlands
Assistance Publique - Hôpitaux de Paris
Novartis Pharmaceuticals

Completed

Rivastigmine in the Management of Delirium (confuriv)

Delirium

France
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Alzheimer's Disease

Japan
Novartis Pharmaceuticals

Completed

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. (CARE)

Alzheimer's Disease

Turkey, Australia, Thailand, Korea, Republic of, Malaysia
Inha University Hospital

Completed

Exelon Patch and Combination With Memantine Comparative Trial (EXPECT)

Alzheimer's Disease

Korea, Republic of
Novartis Pharmaceuticals

Terminated

Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment (EXCITING)

Multiple Sclerosis | Cognitive Impairment

Germany
VA Office of Research and Development

Completed

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI (RIVET)

Cognitive Impairment | Traumatic Brain Injury

United States
Novartis

Completed

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) (EXTRA)

Alzheimer's Disease

France
Ain Shams University

Completed

Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium

Delirium

Egypt
University Hospital, Lille

Completed

Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia (CHoPA-I)

Parkinson's Disease | Apathy | no Dementia

France
Novartis Pharmaceuticals

Completed

A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease

Alzheimer's Disease

China
Northwestern University
3M

Completed

Tolerability Study of the Application of a 3M Microstructure Transdermal System

Healthy

United States
Novartis Pharmaceuticals

Completed

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. (ENA1stepswitch)

Mild to Moderate Alzheimer's Disease

Japan
Mundipharma Pte Ltd.
Mundipharma Korea Ltd; Mundipharma (Hong Kong) Ltd; Mundipharma Distribution...

Completed

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Osteoarthritis | Rheumatoid Arthritis | Lower Back Pain | Joint Pain | Muscle Pain

Hong Kong, Korea, Republic of, Philippines
Novartis Pharmaceuticals

Completed

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Alzheimer Disease

United States, Germany, Italy, Spain, France, Canada, Switzerland
Novartis

Completed

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (KAPA)

Alzheimer's Disease

Spain
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

Substance Abuse | Cocaine Dependence | Cocaine Abuse | Cocaine Addiction

United States
SocraTec R&D GmbH
SocraMetrics GmbH

Completed

Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase

Bioequivalence

Germany
Federal University of Bahia

Completed

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients

Alzheimer Disease

Brazil
Mundipharma AB

Completed

A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol

Osteoarthritis

Sweden
Chinese Chronic Respiratory Disease Research Network

Recruiting

Lung Nodule Intervention Cohort Study (LNICS)

Incident Lung Nodule

China
Novartis

Completed

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 (ACTION)

Alzheimer's Disease

United States, Puerto Rico
Banner Health
Phoenix Children's Hospital

Completed

Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion

Toxicity

United States
University Hospital Tuebingen

Unknown

Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy (psp)

Dementia | Progressive Supranuclear Palsy

Germany
MediBeacon

Recruiting

Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring

Kidney Diseases | Kidney Injury | Kidney Failure

United States
MediBeacon

Completed

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Chronic Kidney Disease

United States, China
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. (BP96-0604)

Back Pain

United States
Singapore General Hospital
Novartis; National Neuroscience Institute

Completed

RIVastigmine In Vascular cognitivE Impairment (RIVIVE)

Cognitive Impairment

Singapore
Duke University
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Taishoff Family...

Completed

Rivastigmine Study in Adolescents With Down Syndrome (DS-Riv)

Down Syndrome

United States
Balmoral Medical company

Not yet recruiting

A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants With Transfemoral Amputations

Prosthesis and Implants
University of Toronto
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Unknown

Comparison of Blood Pressure Measurements Between Transdermal Optical Imaging and Standard of Care

Blood Pressure

Canada, China
Somerset Pharmaceuticals

Completed

Evaluation of Adhesion and Dermal Tolerability of EMSAM

Healthy

United States
Seoul National University Hospital
Seoul St. Mary's Hospital; Pusan National University Hospital; Seoul National... and other collaborators

Completed

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients (X-MEN)

Alzheimer's Disease

Korea, Republic of
James BOYD MD
Michael J. Fox Foundation for Parkinson's Research; Philipps University Marburg... and other collaborators

Unknown

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

Parkinson's Disease

United States, Germany
Purdue Pharma LP

Terminated

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

Osteoarthritis

United States
Zynerba Pharmaceuticals, Inc.

Enrolling by invitation

Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

Fragile X Syndrome

United States, United Kingdom, New Zealand, Australia
Radius Health, Inc.
Nordic Bioscience A/S

Completed

Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis

Post Menopausal Osteoporosis

Poland, Denmark, United States, Estonia
Kuopio University Hospital

Completed

Rivastigmine in Mild Alzheimer's Disease, FMRI Study (ADFRMI)

Alzheimer' Disease

Finland
Amsterdam UMC, location VUmc
University Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaborators

Terminated

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease (CHEVAL)

Parkinson's Disease

Netherlands

Search clinical trials for: Rivastigmine Transdermal System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations